‘Green Light’ on Daewoong Pharmaceutical with Nabota’s USAN registration

Daewoong Pharmaceutical(CEO Jong-Wook Lee) announced a U.S. medical substance name for ‘Nabota,’ a botulinum toxin, was registered as ‘prabotulinumtoxin A.’

The USAN(United States Adopted Names) is one of the international drug names, officially sponsored by the American Medical Association(AMA).

It is essential to acquire a USAN and approval to launch a drug in the U.S. A purpose of this is ...